FocalTherics $FOCL Shares Purchased by Rock Springs Capital Management LP

Rock Springs Capital Management LP increased its holdings in shares of FocalTherics (NASDAQ:FOCL) by 7.1% in the first quarter, Holdings Channel reports. The firm owned 1,378,000 shares of the company’s stock after buying an additional 91,500 shares during the quarter. Rock Springs Capital Management LP’s holdings in FocalTherics were worth $5,126,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Financial Planning Navigators CORP purchased a new stake in shares of FocalTherics in the fourth quarter valued at about $33,000. SmartHarvest Portfolios LLC purchased a new position in shares of FocalTherics during the first quarter worth about $38,000. Lido Advisors LLC purchased a new position in shares of FocalTherics during the first quarter worth about $40,000. Kovack Advisors Inc. acquired a new position in FocalTherics in the 4th quarter valued at about $53,000. Finally, Leonteq Securities AG acquired a new position in FocalTherics in the 4th quarter valued at about $313,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

FOCL has been the subject of several analyst reports. Mizuho set a $15.00 price objective on FocalTherics and gave the company an “outperform” rating in a research note on Friday, July 17th. HC Wainwright reiterated a “buy” rating and issued a $10.00 target price on shares of FocalTherics in a research note on Tuesday, June 2nd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $9.00.

Insider Buying and Selling

In other FocalTherics news, Director Joshua Levine acquired 10,000 shares of the stock in a transaction on Monday, May 11th. The shares were bought at an average price of $4.22 per share, with a total value of $42,200.00. Following the acquisition, the director owned 35,000 shares of the company’s stock, valued at $147,700. This trade represents a 40.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 10.10% of the stock is currently owned by insiders.

FocalTherics Stock Performance

FOCL stock opened at $6.15 on Tuesday. FocalTherics has a one year low of $1.21 and a one year high of $6.18. The firm has a market capitalization of $230.50 million, a PE ratio of -7.59 and a beta of -0.04. The company has a quick ratio of 0.99, a current ratio of 1.34 and a debt-to-equity ratio of 1.79.

FocalTherics (NASDAQ:FOCL) last issued its earnings results on Thursday, May 7th. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.02). FocalTherics had a negative net margin of 41.47% and a negative return on equity of 137.61%. The firm had revenue of $20.48 million during the quarter, compared to analysts’ expectations of $19.46 million. As a group, equities analysts anticipate that FocalTherics will post -0.78 earnings per share for the current fiscal year.

FocalTherics Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications.